Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Weiskirchen

Showing results (21-30 of 501) with videos related to

Pageof 51
Sort By:
Hepatobiliary Surgery and Nutrition|April 27, 2016
Intratumor heterogeneity, variability and plasticity: questioning the current concepts in classification and treatment of hepatocellular carcinomaRalf Weiskirchen
Frontiers in Public Health|December 1, 2022
Commentary: Crocetin protected human hepatocyte LO2 cell from TGF-β-induced oxygen stress and apoptosis but promoted proliferation and autophagy <i>via</i> AMPK/m-TOR pathwayRalf Weiskirchen
Cells|August 12, 2022
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"Ralf Weiskirchen
Cells|May 6, 2020
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"Ralf Weiskirchen
Cells|January 24, 2025
Topic "Signaling Pathways in Liver Disease"Ralf Weiskirchen
Frontiers in Pharmacology|November 12, 2019
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver InjuryRalf Weiskirchen
British Journal of Pharmacology|October 21, 2020
Commentary on "Re-regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signaling via interaction with Gli1"Ralf Weiskirchen
British Journal of Pharmacology|August 19, 2021
Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activationRalf Weiskirchen
Medical Sciences (Basel, Switzerland)|January 21, 2026
Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive ReviewRalf Weiskirchen
RSC Advances|November 17, 2025
Comment on "Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives" by J.-X. Lu, H.-R. Lan, D. Zeng, J.-Y. Song, Y.-T. Hao, A.-P. Xing, A. Shen, and J. Yuan, <i>RSC Adv.</i>, 2025, <b>15</b>, 231-243Ralf Weiskirchen
Pageof 51

Showing results (21-30 of 501) with videos related to

Sort By:
Pageof 51
Hepatobiliary Surgery and Nutrition|April 27, 2016
Intratumor heterogeneity, variability and plasticity: questioning the current concepts in classification and treatment of hepatocellular carcinomaRalf Weiskirchen
Frontiers in Public Health|December 1, 2022
Commentary: Crocetin protected human hepatocyte LO2 cell from TGF-β-induced oxygen stress and apoptosis but promoted proliferation and autophagy <i>via</i> AMPK/m-TOR pathwayRalf Weiskirchen
Cells|August 12, 2022
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"Ralf Weiskirchen
Cells|May 6, 2020
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"Ralf Weiskirchen
Cells|January 24, 2025
Topic "Signaling Pathways in Liver Disease"Ralf Weiskirchen
Frontiers in Pharmacology|November 12, 2019
Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver InjuryRalf Weiskirchen
British Journal of Pharmacology|October 21, 2020
Commentary on "Re-regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt/β-catenin signaling via interaction with Gli1"Ralf Weiskirchen
British Journal of Pharmacology|August 19, 2021
Physalin B attenuates liver fibrosis via suppressing LAP2α-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activationRalf Weiskirchen
Medical Sciences (Basel, Switzerland)|January 21, 2026
Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive ReviewRalf Weiskirchen
RSC Advances|November 17, 2025
Comment on "Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives" by J.-X. Lu, H.-R. Lan, D. Zeng, J.-Y. Song, Y.-T. Hao, A.-P. Xing, A. Shen, and J. Yuan, <i>RSC Adv.</i>, 2025, <b>15</b>, 231-243Ralf Weiskirchen
Pageof 51